Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

Nature

Volumn 418, Issue 6898, 2002, Pages 646-650

  Sheehy, Ann M ^a   Gaddis, Nathan C ^a   Choi, Jonathan D ^a   Malim, Michael H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; PROTEINS; VIRUSES;

ANTIVIRAL PHENOTYPE;

GENES;

PROTEIN; PROTEIN CEM15; UNCLASSIFIED DRUG; VIF PROTEIN;

GENE; HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CEM15 GENE; CONTROLLED STUDY; GENE; GENE ISOLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS EXAMINATION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE; CLONING, MOLECULAR; GENE DELETION; GENE PRODUCTS, VIF; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOSIDE DEAMINASES; PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES; VIRION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; RNA VIRUSES;

EID: 0037043699     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature00939     Document Type: Article

References (30)

1. Identification of highly attenuated mutants of simian immunodeficiency virus
2. The sor gene of HIV-1 is required for efficient virus transmission in vitro
3. + T lymphocytes
4. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: A role for Vif in determining virus host range and cross-species transmission
5. The HIV "A" (sor) gene product is essential for virus infectivity
6. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
7. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
8. Evidence for a newly discovered cellular anti-HIV-1 phenotype
9. Loss of neoplastic properties in vitro. II. Observations on KB sublines
10. Quantitative infectivity assay for HIV-1 and -2
11. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein
12. Characterization of human immunodeficiency virus type 1 Vif particle incorporation
13. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
14. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures
15. Molecular cloning of an apolipoprotein B messenger RNA editing protein
16. Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1
17. Cytosine nucleoside/nucleotide deaminases and apolipoprotein B mRNA editing
18. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity
19. Mutations affecting transition-state stabilization by residues coordinating zinc at the active site of cytidine deaminase
20. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription
21. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA
22. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process
23. Peripheral blood mononuclear cells produce normal amounts of defective Vif-human immunodeficiency virus type 1 particle which are restricted for the preretrotranscription steps
24. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
25. Efficiency of viral DNA synthesis during infection of permissive and non-permissive cells with vif-negative human immunodeficiency virus type 1
26. Fv-I restriction and its effects on murine leukemia virus integration in vivo and in vitro
27. A conserved mechanism of retrovirus restriction in mammals
28. HIV-1 infection of nondividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import
29. Efficient and rapid induction of a chronic myelagenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
30. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells